New double chin treatment shows promise in small study
NCT ID NCT06509438
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This study tested a new injectable drug called Embella (deoxycholic acid) to reduce submental fat, commonly known as a double chin. Twenty adults with unwanted chin fat received the treatment to see if it was safe and effective. The goal was to improve the appearance of the chin area without surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBMENTAL FULLNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Research and Training in Skin Diseases and Leprosy
Tehran, 1416613675, Iran
Conditions
Explore the condition pages connected to this study.